nodes	percent_of_prediction	percent_of_DWPC	metapath
Olmesartan—SLCO1B3—Rifampicin—leprosy	0.431	0.477	CbGbCtD
Olmesartan—SLCO1B1—Rifampicin—leprosy	0.251	0.278	CbGbCtD
Olmesartan—ABCC2—Rifampicin—leprosy	0.221	0.244	CbGbCtD
Olmesartan—Electrolyte imbalance—Thalidomide—leprosy	0.00312	0.0321	CcSEcCtD
Olmesartan—Toothache—Thalidomide—leprosy	0.00214	0.022	CcSEcCtD
Olmesartan—Hyperlipidaemia—Thalidomide—leprosy	0.00181	0.0186	CcSEcCtD
Olmesartan—Nasopharyngitis—Dapsone—leprosy	0.00165	0.017	CcSEcCtD
Olmesartan—Influenza—Dapsone—leprosy	0.0016	0.0164	CcSEcCtD
Olmesartan—Pancreatitis—Dapsone—leprosy	0.00157	0.0161	CcSEcCtD
Olmesartan—Jaundice cholestatic—Thalidomide—leprosy	0.00148	0.0153	CcSEcCtD
Olmesartan—Photosensitivity reaction—Dapsone—leprosy	0.00146	0.015	CcSEcCtD
Olmesartan—Viral infection—Thalidomide—leprosy	0.00144	0.0148	CcSEcCtD
Olmesartan—Hyperbilirubinaemia—Thalidomide—leprosy	0.00143	0.0147	CcSEcCtD
Olmesartan—Hyperuricaemia—Thalidomide—leprosy	0.00141	0.0144	CcSEcCtD
Olmesartan—Hypercholesterolaemia—Thalidomide—leprosy	0.00138	0.0142	CcSEcCtD
Olmesartan—Bone pain—Thalidomide—leprosy	0.00136	0.014	CcSEcCtD
Olmesartan—Sinusitis—Dapsone—leprosy	0.00134	0.0137	CcSEcCtD
Olmesartan—Blood uric acid increased—Thalidomide—leprosy	0.00133	0.0136	CcSEcCtD
Olmesartan—Hyperkalaemia—Thalidomide—leprosy	0.00128	0.0132	CcSEcCtD
Olmesartan—Pharyngitis—Dapsone—leprosy	0.00127	0.013	CcSEcCtD
Olmesartan—Blood urea increased—Thalidomide—leprosy	0.00123	0.0127	CcSEcCtD
Olmesartan—Aplastic anaemia—Thalidomide—leprosy	0.00122	0.0126	CcSEcCtD
Olmesartan—Lightheadedness—Thalidomide—leprosy	0.00117	0.012	CcSEcCtD
Olmesartan—Diabetes mellitus—Thalidomide—leprosy	0.00109	0.0112	CcSEcCtD
Olmesartan—Gastroenteritis—Thalidomide—leprosy	0.00107	0.011	CcSEcCtD
Olmesartan—Eczema—Thalidomide—leprosy	0.00105	0.0108	CcSEcCtD
Olmesartan—Vision blurred—Dapsone—leprosy	0.00105	0.0108	CcSEcCtD
Olmesartan—Injury—Thalidomide—leprosy	0.00103	0.0106	CcSEcCtD
Olmesartan—Renal failure acute—Thalidomide—leprosy	0.00103	0.0105	CcSEcCtD
Olmesartan—Vertigo—Dapsone—leprosy	0.001	0.0103	CcSEcCtD
Olmesartan—Arthritis—Thalidomide—leprosy	0.000974	0.01	CcSEcCtD
Olmesartan—Cough—Dapsone—leprosy	0.000972	0.00999	CcSEcCtD
Olmesartan—Lethargy—Thalidomide—leprosy	0.000966	0.00993	CcSEcCtD
Olmesartan—Hyponatraemia—Thalidomide—leprosy	0.000951	0.00977	CcSEcCtD
Olmesartan—Pain in extremity—Thalidomide—leprosy	0.000947	0.00973	CcSEcCtD
Olmesartan—Face oedema—Thalidomide—leprosy	0.000914	0.00939	CcSEcCtD
Olmesartan—Tachycardia—Dapsone—leprosy	0.000887	0.00912	CcSEcCtD
Olmesartan—Blood creatinine increased—Thalidomide—leprosy	0.000887	0.00911	CcSEcCtD
Olmesartan—Orthostatic hypotension—Thalidomide—leprosy	0.000865	0.00888	CcSEcCtD
Olmesartan—Hypokalaemia—Thalidomide—leprosy	0.000862	0.00885	CcSEcCtD
Olmesartan—Toxic epidermal necrolysis—Thalidomide—leprosy	0.000853	0.00876	CcSEcCtD
Olmesartan—Aspartate aminotransferase increased—Thalidomide—leprosy	0.000853	0.00876	CcSEcCtD
Olmesartan—Alanine aminotransferase increased—Thalidomide—leprosy	0.000835	0.00858	CcSEcCtD
Olmesartan—Insomnia—Dapsone—leprosy	0.000822	0.00845	CcSEcCtD
Olmesartan—Influenza—Thalidomide—leprosy	0.000818	0.00841	CcSEcCtD
Olmesartan—Eosinophilia—Thalidomide—leprosy	0.00081	0.00832	CcSEcCtD
Olmesartan—Pancreatitis—Thalidomide—leprosy	0.000802	0.00824	CcSEcCtD
Olmesartan—Angina pectoris—Thalidomide—leprosy	0.000797	0.00819	CcSEcCtD
Olmesartan—Bronchitis—Thalidomide—leprosy	0.000787	0.00809	CcSEcCtD
Olmesartan—Pancytopenia—Thalidomide—leprosy	0.000777	0.00798	CcSEcCtD
Olmesartan—Neutropenia—Thalidomide—leprosy	0.000765	0.00786	CcSEcCtD
Olmesartan—Upper respiratory tract infection—Thalidomide—leprosy	0.00076	0.00781	CcSEcCtD
Olmesartan—Erectile dysfunction—Thalidomide—leprosy	0.000754	0.00774	CcSEcCtD
Olmesartan—Photosensitivity reaction—Thalidomide—leprosy	0.000747	0.00767	CcSEcCtD
Olmesartan—Gastrointestinal pain—Dapsone—leprosy	0.000743	0.00764	CcSEcCtD
Olmesartan—Hyperglycaemia—Thalidomide—leprosy	0.000738	0.00758	CcSEcCtD
Olmesartan—Pneumonia—Thalidomide—leprosy	0.000734	0.00754	CcSEcCtD
Olmesartan—Infestation NOS—Thalidomide—leprosy	0.00073	0.0075	CcSEcCtD
Olmesartan—Infestation—Thalidomide—leprosy	0.00073	0.0075	CcSEcCtD
Olmesartan—Body temperature increased—Dapsone—leprosy	0.000719	0.00738	CcSEcCtD
Olmesartan—Abdominal pain—Dapsone—leprosy	0.000719	0.00738	CcSEcCtD
Olmesartan—Renal failure—Thalidomide—leprosy	0.000717	0.00737	CcSEcCtD
Olmesartan—Haematuria—Thalidomide—leprosy	0.000696	0.00715	CcSEcCtD
Olmesartan—Sinusitis—Thalidomide—leprosy	0.000684	0.00703	CcSEcCtD
Olmesartan—Agranulocytosis—Thalidomide—leprosy	0.000681	0.007	CcSEcCtD
Olmesartan—Rhinitis—Thalidomide—leprosy	0.000657	0.00675	CcSEcCtD
Olmesartan—Pharyngitis—Thalidomide—leprosy	0.00065	0.00668	CcSEcCtD
Olmesartan—Urinary tract disorder—Thalidomide—leprosy	0.000647	0.00665	CcSEcCtD
Olmesartan—Oedema peripheral—Thalidomide—leprosy	0.000645	0.00663	CcSEcCtD
Olmesartan—Urethral disorder—Thalidomide—leprosy	0.000642	0.0066	CcSEcCtD
Olmesartan—Angiopathy—Thalidomide—leprosy	0.000594	0.00611	CcSEcCtD
Olmesartan—Mediastinal disorder—Thalidomide—leprosy	0.00059	0.00607	CcSEcCtD
Olmesartan—Arrhythmia—Thalidomide—leprosy	0.000585	0.00601	CcSEcCtD
Olmesartan—Alopecia—Thalidomide—leprosy	0.000579	0.00595	CcSEcCtD
Olmesartan—Vomiting—Dapsone—leprosy	0.000578	0.00594	CcSEcCtD
Olmesartan—Mental disorder—Thalidomide—leprosy	0.000574	0.0059	CcSEcCtD
Olmesartan—Malnutrition—Thalidomide—leprosy	0.00057	0.00586	CcSEcCtD
Olmesartan—Headache—Dapsone—leprosy	0.000569	0.00585	CcSEcCtD
Olmesartan—Back pain—Thalidomide—leprosy	0.000551	0.00567	CcSEcCtD
Olmesartan—Muscle spasms—Thalidomide—leprosy	0.000548	0.00563	CcSEcCtD
Olmesartan—Nausea—Dapsone—leprosy	0.00054	0.00555	CcSEcCtD
Olmesartan—Vision blurred—Thalidomide—leprosy	0.000537	0.00552	CcSEcCtD
Olmesartan—Ill-defined disorder—Thalidomide—leprosy	0.000529	0.00544	CcSEcCtD
Olmesartan—Anaemia—Thalidomide—leprosy	0.000527	0.00541	CcSEcCtD
Olmesartan—Agitation—Thalidomide—leprosy	0.000524	0.00538	CcSEcCtD
Olmesartan—Angioedema—Thalidomide—leprosy	0.000521	0.00535	CcSEcCtD
Olmesartan—Malaise—Thalidomide—leprosy	0.000514	0.00528	CcSEcCtD
Olmesartan—Vertigo—Thalidomide—leprosy	0.000512	0.00526	CcSEcCtD
Olmesartan—Syncope—Thalidomide—leprosy	0.000511	0.00525	CcSEcCtD
Olmesartan—Leukopenia—Thalidomide—leprosy	0.00051	0.00524	CcSEcCtD
Olmesartan—Palpitations—Thalidomide—leprosy	0.000504	0.00518	CcSEcCtD
Olmesartan—Loss of consciousness—Thalidomide—leprosy	0.000501	0.00515	CcSEcCtD
Olmesartan—Cough—Thalidomide—leprosy	0.000498	0.00511	CcSEcCtD
Olmesartan—Myalgia—Thalidomide—leprosy	0.000485	0.00499	CcSEcCtD
Olmesartan—Arthralgia—Thalidomide—leprosy	0.000485	0.00499	CcSEcCtD
Olmesartan—Chest pain—Thalidomide—leprosy	0.000485	0.00499	CcSEcCtD
Olmesartan—Anxiety—Thalidomide—leprosy	0.000484	0.00497	CcSEcCtD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.000482	0.00495	CcSEcCtD
Olmesartan—Discomfort—Thalidomide—leprosy	0.00048	0.00493	CcSEcCtD
Olmesartan—Oedema—Thalidomide—leprosy	0.000465	0.00478	CcSEcCtD
Olmesartan—Infection—Thalidomide—leprosy	0.000462	0.00475	CcSEcCtD
Olmesartan—Shock—Thalidomide—leprosy	0.000458	0.0047	CcSEcCtD
Olmesartan—Nervous system disorder—Thalidomide—leprosy	0.000456	0.00469	CcSEcCtD
Olmesartan—Thrombocytopenia—Thalidomide—leprosy	0.000456	0.00468	CcSEcCtD
Olmesartan—Tachycardia—Thalidomide—leprosy	0.000454	0.00467	CcSEcCtD
Olmesartan—Skin disorder—Thalidomide—leprosy	0.000452	0.00464	CcSEcCtD
Olmesartan—Hyperhidrosis—Thalidomide—leprosy	0.00045	0.00462	CcSEcCtD
Olmesartan—Anorexia—Thalidomide—leprosy	0.000444	0.00456	CcSEcCtD
Olmesartan—Hypotension—Thalidomide—leprosy	0.000435	0.00447	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Thalidomide—leprosy	0.000424	0.00436	CcSEcCtD
Olmesartan—Insomnia—Thalidomide—leprosy	0.000421	0.00432	CcSEcCtD
Olmesartan—Dyspepsia—Thalidomide—leprosy	0.00041	0.00421	CcSEcCtD
Olmesartan—Decreased appetite—Thalidomide—leprosy	0.000404	0.00416	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Thalidomide—leprosy	0.000402	0.00413	CcSEcCtD
Olmesartan—Fatigue—Thalidomide—leprosy	0.000401	0.00412	CcSEcCtD
Olmesartan—Pain—Thalidomide—leprosy	0.000398	0.00409	CcSEcCtD
Olmesartan—Constipation—Thalidomide—leprosy	0.000398	0.00409	CcSEcCtD
Olmesartan—Feeling abnormal—Thalidomide—leprosy	0.000383	0.00394	CcSEcCtD
Olmesartan—Gastrointestinal pain—Thalidomide—leprosy	0.00038	0.00391	CcSEcCtD
Olmesartan—Urticaria—Thalidomide—leprosy	0.00037	0.0038	CcSEcCtD
Olmesartan—Abdominal pain—Thalidomide—leprosy	0.000368	0.00378	CcSEcCtD
Olmesartan—Body temperature increased—Thalidomide—leprosy	0.000368	0.00378	CcSEcCtD
Olmesartan—Asthenia—Thalidomide—leprosy	0.000334	0.00343	CcSEcCtD
Olmesartan—Pruritus—Thalidomide—leprosy	0.000329	0.00338	CcSEcCtD
Olmesartan—Diarrhoea—Thalidomide—leprosy	0.000318	0.00327	CcSEcCtD
Olmesartan—Dizziness—Thalidomide—leprosy	0.000308	0.00316	CcSEcCtD
Olmesartan—Vomiting—Thalidomide—leprosy	0.000296	0.00304	CcSEcCtD
Olmesartan—Rash—Thalidomide—leprosy	0.000293	0.00301	CcSEcCtD
Olmesartan—Dermatitis—Thalidomide—leprosy	0.000293	0.00301	CcSEcCtD
Olmesartan—Headache—Thalidomide—leprosy	0.000291	0.003	CcSEcCtD
Olmesartan—Nausea—Thalidomide—leprosy	0.000276	0.00284	CcSEcCtD
